Navigation Links
Butamax™ Responds to Gevo Patent Infringement Lawsuit
Date:4/10/2012

WILMINGTON, Del., April 10, 2012 /PRNewswire/ -- Butamax™ Advanced Biofuels, LLC, the biobutanol technology leader, commented on the lawsuit filed by Gevo today alleging patent infringement.

(Logo: http://photos.prnewswire.com/prnh/20120209/MM50763LOGO )

"Certain innovative technology is critical for commercial production of isobutanol.  This is especially true for the fundamental biosynthetic pathway claimed in our '188, '889 and related patents filed by Butamax several years ago," said Paul Beckwith, Butamax CEO.  "However, it is our view that the obvious modifications claimed in this recent Gevo patent, reliant on the fundamental pathway, are in fact not critical for our commercialization strategy."

The Butamax patents which are the subject of a lawsuit filed by Butamax against Gevo cover microorganisms which have been engineered to express the required enzymes for isobutanol production, methods of using these microorganisms as well as techniques for recovering isobutanol.  Accordingly, these patents cover fundamental steps for commercial production.  The trial date for the Butamax lawsuit is scheduled for April 2013. 

About Butamax

Butamax™ Advanced Biofuels, LLC was formed to develop and commercialize biobutanol as a next generation renewable biofuel for the transport market. The company benefits from the synergy of DuPont's proven industrial biotechnology experience and BP's global fuels market knowledge. Butamax's proprietary technology offers a cost-advantaged manufacturing process for isobutanol with value from field to pump. For more information, visit www.butamax.com.  

Butamax™ is a trademark of Butamax™ Advanced Biofuels, LLC.

Media Contact:
Pam Schools 910-777-7119
pamela.schools@butamax.com


'/>"/>
SOURCE Butamax Advanced Biofuels, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Icahn Responds to Cornelius
2. NeurogesX Responds to EMEAs Day 120 Questions
3. HealthCore Responds to Need for Real-world Health Outcomes Information on Drugs and Devices with Physician Network and Prospective Effectiveness Research
4. Amylin Responds to Eastbourne Letter
5. Sanofi Pasteur Responds to Nations Need for Hib Vaccine With Increased Supply
6. Immucor Responds To FDA Notice
7. Viral Genetics Responds to Rumors of Imminent FDA Filing and Third Party Press Releases
8. China Sky One Medical, Inc. Responds to Concerns Regarding Filed Financial Reports
9. Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification
10. China Biologic Products Responds to Allegations on Financial Websites
11. Burrill & Company Responds to Recent Press Coverage About Biopark Investment at Elk Run
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Falls Church, VA (PRWEB) , ... ... ... a first-year cybersecurity conference presented by Bloomsburg University’s Digital Forensics Club, takes ... Bloomsburg, PA. The two-day event features 20+ speakers and activities such as ...
(Date:2/4/2016)... , Feb. 4, 2016  CytoSorbents Corporation ... leader commercializing its flagship CytoSorb® blood filter to ... patients around the world, announced that CEO Dr. ... at the Source Capital Group,s 2016 Disruptive Growth ... on the company.  Conference Presentation ...
(Date:2/4/2016)... , February 4, 2016 --> ... biotechnology acceleration company is pleased to provide the following update ... --> Over the last 3 months we have significantly ... purchase agreements exceeding $1,000,000. As a result, we have positioned ... Research Inc. license agreement and expect that development to continue ...
(Date:2/4/2016)... , Feb. 4, 2016  Spherix Incorporated (Nasdaq: ... the fostering and monetization of intellectual property, today provided ... Uniden in the Northern District of Texas ... forward.  Inter Partes Re-examination ("IPR") ... Patent Office.  The IPR was initiated on only certain ...
Breaking Biology Technology:
(Date:2/2/2016)... Feb. 2, 2016  BioMEMS devices deployed ... focused on medical screening and diagnostic applications, ... Wearable devices that facilitate and assure continuous ... movement are being bolstered through new opportunities ... signal acquisition coupled with wireless connectivity and ...
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
(Date:2/2/2016)... 2016   Parabon NanoLabs (Parabon) announced ... Research Office and the Defense Forensics and Biometrics ... the company,s Snapshot Kinship Inference software ... generally, defense-related DNA forensics.  Although Snapshot is best ... and ancestry from DNA evidence), it also has ...
Breaking Biology News(10 mins):